🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)My appetite is literally gone is this normal at 10mg — November 2025 Page 5

My appetite is literally gone is this normal at 10mg — November 2025

PeptideSynthNJ Thu, May 30, 2024 at 7:10 AM 45 replies 2,266 viewsPage 5 of 9
SkepticalSean
Member
98
345
Jan 2025
Maine
Jun 2, 2024 at 5:09 PM#21

Following on from TrialTracker_MD — and this may be the naive question:

What did you change at the same time, and can you separate the two now?

47 20DerekSJ_a1c, paige_pharma, emma_london and 44 others
Reply Quote Save Share Report
bbq_ray_KC
Member
378
1,678
Jul 2024
Kansas City, KS
Jun 3, 2024 at 8:04 AM#22
anna.melb_AU said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

I read this differently from anna.melb_AU, on substance rather than tone. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

Last edited: Jun 3, 2024 at 10:04 AM
48 21MikeFit_NJ, InsuranceTom, WendyG_ATL and 45 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Jun 3, 2024 at 10:59 PM#23
anna.melb_AU said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

Last edited: Jun 4, 2024 at 12:59 AM
49 22stefan_berlin, Dr.EM_Chicago, pete_RVA and 46 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Jun 4, 2024 at 1:53 PM#24
anna.melb_AU said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

This is exactly what I could not find anywhere else.

50 23pete_RVA, CarlaRPh_TPA, steph_laguna and 47 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Jun 5, 2024 at 4:47 AM#25

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Correct me if the detail matters more than I have assumed.

Last edited: Jun 5, 2024 at 5:47 AM
1 24carl_compliance
Reply Quote Save Share Report
1345679

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register